TCCC-CMC Practice Test 2026 – Complete Exam Prep for Combat Medics

Meloxicam is classified as a non-steroidal anti-inflammatory drug (NSAID) that has a unique characteristic in its mechanism of action compared to many other NSAIDs. Notably, it is considered a selective COX-2 inhibitor, which means it preferentially inhibits the COX-2 enzyme that is responsible for inflammation and pain, while sparing the COX-1 enzyme, which plays a role in maintaining normal platelet function as well as protecting the stomach lining.

This spares platelet function because COX-1 is involved in the production of thromboxane A2, a substance that promotes platelet aggregation. By selectively inhibiting COX-2, meloxicam reduces inflammation and pain with potentially less risk of interfering with the normal clotting process compared to non-selective NSAIDs that inhibit both COX-1 and COX-2. This characteristic makes it a suitable option for patients who may be at risk of bleeding or have specific cardiovascular concerns.

In summary, the ability of meloxicam to spare platelet function is an important aspect that can guide its use and distinguish it from other NSAIDs that may have a more comprehensive inhibitory effect on both COX-1 and COX-2, thus affecting platelet aggregation and